
Overview
Otis Brawley is professor of oncology at the Johns Hopkins University School of Medicine and 39th Bloomberg Distinguished Professor at Johns Hopkins. Dr. Brawley leads a broad interdisciplinary research effort of cancer health disparities at the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins Kimmel Cancer Center, working to close racial, economic and social disparities in the prevention, detection and treatment of cancer in the United States and worldwide. He also directs community outreach programs for underserved populations throughout Maryland as the Kimmel Cancer Center’s associate director for community outreach and engagement. A former professor of oncology and hematology and deputy director for cancer control at the Winship Cancer Institute at Emory University in Atlanta, Dr. Brawley is a member of the National Academy of Medicine and recently received the Martin D. Abeloff Award for Excellence in Public Health and Cancer Control from the Maryland State Council of Cancer Control. The award, named after the director of the Kimmel Cancer Center from 1992 until his death in 2007, was established to recognize advancements made in cancer control practices that influenced the field of public health on a statewide, national or global scale. A graduate of the University of Chicago’s Pritzker School of Medicine, he completed an internal medicine residency at University Hospitals of Cleveland, Case-Western Reserve University and a fellowship in medical oncology at the National Cancer Institute.
Dr. Brawley is highly rated in 3 conditions, according to our data. His top areas of expertise are Prostate Cancer, Triple-Negative Breast Cancer, Breast Cancer, Prostatectomy, and Colonoscopy.
His clinical research consists of co-authoring 137 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
10803 Falls Road, Pavilion III STE 1500, Pavilion III STE 1500, Lutherville, MD 21093
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Nirmish Singla is an Oncologist in Lutherville, Maryland. Dr. Singla is highly rated in 26 conditions, according to our data. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Orchiectomy.
Office
Taofeek Owonikoko is a Hematologist and an Oncologist in Baltimore, Maryland. Dr. Owonikoko is highly rated in 18 conditions, according to our data. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.
Skip Viragh Outpatient Cancer Center
Dr. Matthias Holdhoff is a medical oncologist and co-director of the Brain Cancer Disease Group at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a professor of oncology, neurology and neurological surgery at Johns Hopkins University School of Medicine. Dr. Holdhoff’s expertise is in primary brain cancers and central nervous system lymphomas. He earned his medical degree from Freie Universität Berlin, received his doctorate degree at Charité University Medicine Berlin. Dr. Holdhoff completed residency training in internal medicine at Johns Hopkins Bayview Medical Center, followed by a fellowship in medical oncology at Johns Hopkins Hospital with research training at the Ludwig Center for Cancer Genetics and Therapeutics (Kinzler-Vogelstein lab). As a clinical investigator in neuro-oncology, his research is focused on novel trials and translational biomarker studies in malignant gliomas and primary central nervous system lymphomas. He has led and contributed to numerous clinical trials, publications and presentations. Dr. Holdhoff serves as the director of the solid tumor inpatient service at the Sidney Kimmel Comprehensive Cancer Center. He is passionately involved in mentoring and teaching of fellows, residents and students. He is the director of the UCNS-certified neuro-oncology fellowship program at Johns Hopkins, and he is a teaching attending physician for the Osler internal medicine residency program. Dr. Holdhoff is highly rated in 19 conditions, according to our data. His top areas of expertise are Glioma, Glioblastoma, Astrocytoma, and Brain Tumor.
Frequently Asked Questions about Dr. Otis Brawley
How do I make an appointment with Dr. Otis Brawley?
You can book an appointment with Dr. Otis Brawley by calling their office at 410-583-2970. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Otis Brawley a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Otis Brawley is classified as an Advanced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Otis Brawley specialize in?
While Dr. Otis Brawley is a Oncology, they have specific expertise in Prostate Cancer, Triple-Negative Breast Cancer, and Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Otis Brawley participate in research or clinical trials?
Yes. Dr. Otis Brawley has published 137 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Otis Brawley's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Otis Brawley accept my insurance?
Dr. Otis Brawley accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 410-583-2970 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Brawley isAdvanced. Learn about Breast Cancer.
- Prostate CancerDr. Brawley isAdvanced. Learn about Prostate Cancer.
- Triple-Negative Breast CancerDr. Brawley isAdvanced. Learn about Triple-Negative Breast Cancer.
- Experienced
- Cervical CancerDr. Brawley isExperienced. Learn about Cervical Cancer.
- ColonoscopyDr. Brawley isExperienced. Learn about Colonoscopy.
- Colorectal CancerDr. Brawley isExperienced. Learn about Colorectal Cancer.
- Endometrial CancerDr. Brawley isExperienced. Learn about Endometrial Cancer.
- Familial Prostate CancerDr. Brawley isExperienced. Learn about Familial Prostate Cancer.
- Lung CancerDr. Brawley isExperienced. Learn about Lung Cancer.

